The Retinoblastoma family member pRb2/p130 is an independent predictor survival in human soft tissue sarcomas

Clinical Cancer Research

Volumn 14, Issue 15, 2008, Pages 4775-4779

  Masciullo, Valeria ^a,d   Berardengo, Ester ^b   Boglione, Antonella ^c   Sgambato, Alessandro ^d   Bernardi, Amelia ^b   Forni, Marco ^c   Linari, Alessandra ^c   Cito, Letizia ^e   Scambia, Giovanni ^d   Comandone, Alessandro ^c   Giordano, Antonio ^a,f  

^a Temple University

^b Department of Pathology

^c GRADENIGO HOSPITAL   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e CROM   (Italy)

^f TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P130; PROTEIN RB2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETINOBLASTOMA; SOFT TISSUE SARCOMA; BIOLOGICAL MODEL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; SARCOMA; SOFT TISSUE TUMOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; PROGNOSIS; RETINOBLASTOMA-LIKE PROTEIN P130; SARCOMA; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME;

EID: 51049109215     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4055     Document Type: Article

References (22)

1. Clark MA, Fisher C, Judson I, Thomas JM. Soft tissue sarcomas in adults. N Eng J Med 2005;353:701-11.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
3. Fletcher CDM, Rydholm A, Singer S, Sundaram M, Coindre JM. World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone. In: Fletcher CDM, Unni KK, Mertens F, editors. Soft tissue tumors: epidemiology clinical features, histopathological typing and grading. Lyon (France): IARC; 2002. p. 12-8.
4. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-89.
5. Stojadinovic A, Leung DH, Allen P, Lewis J J, Jaques DP, Brennan MF. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol 2002:20;4344-52.
6. Claudio PP, Howard CM, Baldi A, et al. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res1994:54:5556-60.
7. DAndrilli G, Masciullo V, Bagella L, et al. Frequent loss of pRb2/p130 in human ovarian carcinoma. Clin Cancer Res 2004;10:3098-103.
8. Caputi M, Groeger AM, Esposito V, et al. Loss of pR2/p130 expression is associated with unfavourable clinical outcome in lung cancer, Clin Cancer Res 2002; 8:3850-6.
9. Susini T, Baldi A, Howard CM, et al. Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer. J Clin Oncol 1998;16:1085-93.
10. Massaro-Giordano M, Baldi G, De Luca A, et al. Differential expression of the retinoblastoma gene family members in choroidal melanoma: prognostic significance. Clin Cancer Res 1999;5:1455-8.
11. Enzinger FM, Weiss SW. Soft tissue tumors. St Louis: Mosby, 1995.
12. Claudio PP, De Luca A, Howard CM, et al. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res 1996;56:2003-8.
13. Baldi A, De Luca A, Claudio PP, et al. The RB2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J Cell Biochem 1995;59:402-8.
14. Wunder JS, Czitrom AA, Kandel R, Andrulis IL. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 1991;83:194-200.
15. Claudio PP, Russo G, Kumar C, et al. pRb2/p130, VEGF, p27 kip1, and PCNA expression in hepatocellular carcinoma: their clinical significance. Clin Cancer Res 2004;10:3509-17.
16. Claudio PP, Howard CM, Fu Y et al. Mutations in the retinoblastoma- related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res 2000;60:8-12.
17. Claudio PP, Howard CM, Pacilio C, et al. Mutations in the retinoblastoma-related gene Rb2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus mediated gene transfer. Cancer Res 2000; 60:372-82.
18. Leoncini L, Bellan C, Cossu A, et al. Retinoiblastoma related p107 and pRb2/p130 in malignant lymphomas: distinct mechanism of cell growth control. Clin Cancer Res 1999;5:4065-72.
19. Xue Jun H, Gemma A, Hosoya Y, et al. Reduced transcription of the RB2/p130 gene in human lung cancer. Mol Carcinog 2003;38:124-9.
20. Tedesco D, Lukas J, Reed SI. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein ubiquitin ligase SCF (Skp2). Genes Dev 2002;16:2946-57.
21. Howard CM, Claudio PP, Gallia GL, et al. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. J Natl Cancer Inst 1998;90:1451-60.
22. Pupa SM, Howard CM, Invernizzi AM, et al. Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overxpressing SKOV3 tumor cell line. Oncogene 1999;18:651-6.